MLchartDataset catalogue

aclarubicin

Term · Oncology and biomedicine · MLC-T-ONC-009608

An oligosaccharide anthracycline antineoplastic antibiotic isolated from the bacterium Streptomyces galilaeus. Aclarubicin intercalates into DNA and interacts with topoisomerases I and II, thereby inhibiting DNA replication and repair and RNA and protein synthesis. Aclarubicin is antagonistic to other agents that inhibit topoisomerase II, such as etoposide, teniposide and amsacrine. This agent is less cardiotoxic than doxorubicin and daunorubicin.

Table 1. Record
IdentifierMLC-T-ONC-009608
FieldOncology and biomedicine
AbbreviationACM
Synonymsaclacinomycin A hydrochloride; aclacinomycin A; aclarubicin hydrochloride; antibiotic MA144-A1; aclacinomycin; aclacinomycin-A
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-009608",
  "term": "aclarubicin",
  "field": "Oncology and biomedicine",
  "definition": "An oligosaccharide anthracycline antineoplastic antibiotic isolated from the bacterium Streptomyces galilaeus. Aclarubicin intercalates into DNA and interacts with topoisomerases I and II, thereby inhibiting DNA replication and repair and RNA and protein synthesis. Aclarubicin is antagonistic to other agents that inhibit topoisomerase II, such as etoposide, teniposide and amsacrine. This agent is less cardiotoxic than doxorubicin and daunorubicin.",
  "abbreviation": "ACM",
  "synonyms": [
    "aclacinomycin A hydrochloride",
    "aclacinomycin A",
    "aclarubicin hydrochloride",
    "antibiotic MA144-A1",
    "aclacinomycin",
    "aclacinomycin-A"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/aclarubicin/"
}

Record 257 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.